Antidepressant use limits serotonin as a marker for neuroendocrine tumor disease activity by lowering of circulating serotonin concentrations.

van Rossum, Huub H; Spruit, Jocelyn; Korse, Catharina M; de Vries, Froukje E; Tesselaar, Margot E T

van Rossum, Huub H; Spruit, Jocelyn; Korse, Catharina M; de Vries, Froukje E; Tesselaar, Margot E T.

Afiliación

van Rossum HH; Department of Laboratory Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands, Phone: +31-20-5122756, Fax: +31-20-5122799.
Spruit J; Department of Psychiatry and the Center for Quality of Life, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Korse CM; Department of Laboratory Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
de Vries FE; Department of Psychiatry and the Center for Quality of Life, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Tesselaar MET; Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Clin Chem Lab Med ; 58(10): e241-e243, 2020 09 25.

Article en En | MEDLINE | ID: mdl-31926073

Asunto(s)

Antidepresivos/uso terapéutico; Biomarcadores de Tumor/sangre; Tumores Neuroendocrinos/sangre; Serotonina/sangre; Antidepresivos/sangre; Humanos

Palabras clave

antidepressant; neuroendocrine tumor (NET); serotonin; serotonin and norepinephrine reuptake inhibitor (SSRI)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Serotonina / Biomarcadores de Tumor / Tumores Neuroendocrinos / Antidepresivos Límite: Humans Idioma: En Revista: Clin Chem Lab Med Asunto de la revista: QUIMICA CLINICA / TECNICAS E PROCEDIMENTOS DE LABORATORIO Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google